Tagged with EALTH

Innovation Axel Schumacher, co-founder and Chief Scientific Officer of Shivom, highlights the need for Big Pharma to adopt new technology. Of course, we know that pharma is often innovation-averse. The healthcare industry has been full of disruptions in the last decade, ranging from the explosive growth of medical devices and the…

Innovation Meghann Chilcott, Senior Vice President of OrderInsite, discusses the changing role of pharmacists and technicians.   Patients are consumers, and they expect more from pharmacies than a collection of pill bottles. Local pharmacists have seen their roles continually change over recent years due to enhanced technology that allows them better…

Spain Enrique Ruiz Escudero, Minister of Health of the Community of Madrid, discusses his strategy to maintain Madrid’s spot as having Spain’s leading healthcare system, the creation of the bio-region –‘Biomad’, and the city’s adoption of innovative telemedicine practices. You took the reins of the Ministry of Health of the Community…

Innovation Article contributed by Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMSS) for PharmaBoardroom. We must assertively bend the arc of technology towards our patients, clinicians, researchers, and caregivers, and re-humanise the health system. One of the many ways patients are de-humanized in a health…

Spain Spanish stakeholders have been trailblazing the concept of the “liquid hospital”, which envisions the virtual and physical expansion of healthcare provision beyond the parameters of the traditional centralized hospital structure. The aim is to leverage connectivity, telemedicine, the Internet of Things (IoT) along with social media to co-opt patients, families…

Turkey Prof. Dr. Sabahattin Aydın, Rector of Medipol University, chairman of the Executive Council of TUSAP Healthcare Platform, former executive board member of the World Health Organization (WHO), former deputy undersecretary (2003-2010) at the Ministry of Health of Turkey, and one of the most respected healthcare leaders in Turkey, provides insights…

Regulation In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), defines ‘fair pricing’, gives the IFPMA’s take on so-called “cost-plus” pricing models, and talks about access to medicine in developing markets.   The innovative pharmaceutical industry seems to be under unprecedented pressure…

Cyprus Healthcare and life science industry advisory services head at KPMG Cyprus, Iacovos Ghalanos, discusses the challenge of implementing the National Health Insurance Scheme, pricing pressures and how their innovative services help companies manage this crucial trend. Ghalanos also touches on the need for greater collaboration between the public and private…

Algeria Reform is under way in Algeria, and professor Mohamed L’Hadj presents the main themes of hospital reform encompassing the roll out of homecare, international collaboration and better training for better outcomes.   What main objectives and priorities are you pursuing today? Our objectives are geared towards our ambition to provide…

Algeria Nadia Oka-Bousbia of bioMérieux Algeria discusses the affiliate’s important role within Algeria’s fight against infectious diseases and the training of health managers, difficulties surrounding import restrictions, and the company’s constantly-evolving strategy for the future.   These are exciting times for bioMérieux locally. We understand that earlier this year, your global…

Cyprus Cyprus is capitalizing on its well-established tourism infrastructure to stake a claim for itself as one of Europe’s premier medical tourism destinations. “I believe Cyprus can become a really important hub for medical tourism thanks to our welcoming culture, great weather and educated talent pool.” Christoforos Hadjikyprianou, CEO of European…

Algeria President of the Health Commission at the Algerian Senate, Louisa Chachoua explores recent changes in Algeria’s healthcare sector, the potential of the new drug agency, and Algeria’s capacity to become a flagship health system for the region. A lot of things have changed since our last encounter, there is a…